References
- 1
Devarajan S, Dursun SM.
Antipsychotic drugs, serum creatinine kinase (CPK) and possible mechanisms (letter
to the editor).
Psychopharmacology.
2000;
152
122
- 2
Holtmann M, Meyer AE, Pitzer M, Schmitt MH.
Risperidone-induced marked elevaton of serum creatine kinase in adolescence: a case
report.
Pharmacopsychiatry.
2003;
36
317-318
- 3
Klein JP, Fielder U, Appel H, Quante A, Jockers-Scherubl MC.
Massive creatine kinase elevations with quetiapine: report of two cases.
Pharmacopsychiatry.
2006;
39
39-40
- 4
Meltzer HY.
Massive serum creatine kinase increases with atypical antipsychotic drugs: what is
the mechanism and the message?.
Psychopharmacology.
2000;
150
349-350
- 5
Meltzer HY, Cola PA, Parsa M.
Marked elevations of serum creatine kinase activity associated with antipsychotic
drug treatment.
Neuropsychopharmacology.
1996;
15
395-405
- 6
Naranjo CA, Busto U, Sellers EM, Sandos P, Ruiz I, Roberts EA. et al .
A method for estimating the probability of adverse drug reactions.
Clin Pharmacol Ther.
1981;
30
239-245
Correspondence
P. OulisMD, PhD
Department of Psychiatry
Eginition Hospital
University of Athens
Vas. Sofias av. 72-74
11528 Athens, Greece
Phone: +30/210/728 94 08
Fax: +30/210/724 20 20
Email: oulisp@med.uoa.gr
